60¢sixtycents

Merck & Co., Inc.MRK

Is MRK cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$144.84+0.91 (+0.63%)24:00 UTC
NYSEHealthcare

Company snapshot

Market Cap
$358B
Mega-cap
+123%
2016 — today
10-Year Price
+152%
2016 — today
52-Week Range
$77.60$156.43
Current $144.84· 85%

Merck & Co. operates through two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment develops medicines and vaccines for oncology, immunology, neuroscience, virology, cardiovascular, and diabetes. The Animal Health segment provides veterinary medications, vaccines, and digital solutions for identification and monitoring. Serving wholesalers, hospitals, and veterinarians, Merck maintains strategic collaborations with AstraZeneca, Bayer, Eisai, and Gilead for HIV therapy development. Established in 1891.

Similar companies

Healthcare companies of comparable size to MRK
CompanyP/EDiv yield
UNHUnitedHealth Group Incorporated24.72.9%
ABBVAbbVie Inc.73.72.6%
NVSNovartis AG21.03.4%
AZNAstraZeneca PLC24.62.0%
TMOThermo Fisher Scientific Inc.33.00.3%
AMGNAmgen Inc.23.72.6%
JNJJohnson & Johnson30.32.0%
NVONovo Nordisk A/S10.74.1%

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
115.9
Near historic high
Near historic highs — last 10 years
Sector median 25.0above sector
P/B ratio
8.5
Near historic high
Near historic highs — last 10 years
Sector median 2.5above sector
EV / EBITDA
29.3
Near historic high
Near historic highs — last 10 years
Sector median 15.4above sector
Dividend Yield
2.3%
Near historic low
Near historic low — last 10 years
Sector median 1.7%above sector
FCF Yield
4.5%
Around average
Around the 10-year average
Sector median -10.1%above sector
Free · No credit card needed

Get alerted when MRK is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.